IPO Premiums
IPO calendar
SPSAROJAListed

Saroja Pharma Industries India Limited

Fixed Price Issue IPO · NSE

Price band
₹84 - ₹84
Lot size
1,600 shares
Issue amount
₹9.11 cr
Total subscription
8.86×
Current price₹40.8
Listing price ₹65
Watch live price ↗
Opens
31 Aug 2023
Closes
5 Sept 2023
Allotment
12 Sept 2023
Listing
13 Sept 2023

Offer at a glance

Issue overview

Issue size
10,84,800 shares
Face value
₹10 per share
Minimum investment
₹1,34,400
Fresh issue
₹9.11 cr
Offer for sale
₹0 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE
Maximum investment
₹1,34,400
Issue type
Fixed Price Issue IPO
Shares before issue
29,35,686
Shares after issue
40,20,486

Lot sizes

CategoryLotsSharesAmount
RETAIL11,600₹1,34,400
HNI23,200₹2,68,800

Share reservation

Retail47.49%
NII(HNI)47.49%
Market Maker5.01%

Subscription & GMP

Subscription by category

Total subscribed8.86×

Missing multiples are calculated from bids and offered shares when available.

NIB2.98×
RETAIL14.74×

GMP history

00.5119 Mar: ₹07 Nov: ₹0
19 Mar₹07 Nov

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
RETAIL4.3363.8
NIB4.3312.9

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
02,0004,0006,000Mar 2023 · Revenue: 5,035.09Mar 2023 · Profit after tax: 106.06Mar 2023Mar 2022 · Revenue: 5,595.67Mar 2022 · Profit after tax: 114.01Mar 2022 Mar 2021 · Revenue: 3,674.67Mar 2021 · Profit after tax: 73.13Mar 2021
RevenueProfit after tax

Key performance indicators

MetricValues
EPS3.61
ROE0.15
ROCE0.25
RONW20.85
PRE IPO(PE)23.27
POST IPO(PE)31.82

Values and labels as reported in the issue data.

Company information

Company profile

Saroja Pharma Industries India Limited, incorporated in 2019, is engaged in trading, exporting, and supplying specialty chemicals and APIs. The company deals in three major product categories: chemicals, pharma intermediaries, and veterinary pharma APIs. It supplies products like Liquid Bromine (used as an agro-intermediate), Ethyl Acetate (used as an API solvent), and other pharma-based chemicals used in human and veterinary medicines. APIs or bulk actives are the key ingredients used in producing finished dosage forms like tablets, capsules, and liquids. The company exports its products to international markets including Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.

Strengths

  • Experienced Promoters and Management Team with strong industry understanding and strategic vision.
  • Scalable Business Model capable of driving growth across markets and geographies.
  • Wide and Diverse Product Portfolio catering to varied customer requirements.
  • Diversified Business Operations and Revenue Base reducing dependency on any single segment.

Promoters

Mr. Biju Gopinathan Nair

Mr. Manish Dasharath Kamble

Objects of the issue

04067162222

Registrar & documents

Lead manager

Swastika Investmart Limited

Registered office

305, Kailash Tower, Shiv Shristi Complex, Goregaon Link Road, Mulund West, Mumbai (MH) – 400080

+91 (022) 2081 0011

[email protected]Company website ↗

Understanding SAROJA IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.